| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
566,876 | 414,991 | 242,926 | 129,040 | 100,468 |
| Cost of Revenue
|
-250,700 | -186,436 | -116,749 | -77,267 | -70,909 |
|
Gross Profit
|
316,176 | 228,555 | 126,177 | 51,773 | 29,559 |
| Selling, General and Administrative Expenses
|
-224,699 | -317,777 | -138,410 | -228,162 | -177,918 |
|
Research and Development Expenses
|
-121,590 | -107,708 | -81,399 | -96,878 | -117,005 |
| Depreciation, Amortization and Depletion
|
-2,447 | -- | -3,281 | -3,614 | -4,146 |
| Other Income/Expense, Operating
|
3,299 | 3,299 | 3,521 | 1,419 | 2,569 |
|
Operating Income/Expenses
|
-342,990 | -422,186 | -216,288 | -327,235 | -296,500 |
|
Total Operating Profit/Loss
|
-26,814 | -193,631 | -90,111 | -275,462 | -266,941 |
| Total Net Finance Income/Expense
|
-1,072 | 232 | 3,932 | 3,625 | 1,835 |
| Net Investment Income
|
386 | 386 | -1,926 | 107 | 36,011 |
| Irregular Income/Expenses
|
-18,284 | 497 | -9,193 | -5,503 | -1,493 |
|
Other Income/Expense, Non-Operating
|
-612,470 | -741,993 | -1,157,692 | -225,586 | -424,543 |
|
Non-Operating Income/Expenses, Total
|
-631,440 | -740,878 | -1,164,879 | -227,357 | -388,190 |
|
Pretax Income
|
-658,254 | -934,509 | -1,254,990 | -502,819 | -655,131 |
|
Provision for Income Tax
|
0 | -50 | 0 | -76 | -95 |
|
Net Income from Continuing Operations
|
-658,254 | -934,559 | -1,254,990 | -502,895 | -655,226 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-658,254 | -934,559 | -1,254,990 | -502,895 | -655,226 |
|
Net Income after Non-Controlling/Minority Interests
|
-658,254 | -934,559 | -1,254,990 | -502,895 | -655,226 |
|
Net Income Available to Common Stockholders
|
-658,254 | -934,559 | -1,254,990 | -502,895 | -655,226 |
|
Diluted Net Income Available to Common Stockholders
|
-658,254 | -934,559 | -1,254,990 | -502,895 | -655,226 |
| Basic EPS
|
-2.53 | -3.20 | -3.84 | -- | -- |
| Diluted EPS
|
-2.53 | -3.20 | -3.84 | -- | -- |
|
Basic Weighted Average Shares Outstanding
|
292,989 | 292,269 | 326,632 | -- | -- |
|
Diluted Weighted Average Shares Outstanding
|
292,989 | 292,269 | 326,632 | -- | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-658,397 | -934,758 | -1,258,925 | -506,444 | -656,966 |
|
EBITDA
|
-644,989 | -924,339 | -1,244,620 | -489,268 | -638,235 |
|
Normalized EBITDA
|
-3,414 | -72,044 | -77,008 | -169,963 | -238,413 |
|
Normalized Income
|
-2,234 | -27,535 | -96,389 | -188,987 | -223,900 |
12/31/2022 - 10/28/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade